why choose us

Clinical Trials Search

Showing 20,320 of 132,963 result(s)
Add-on Reparixin in Adult Patients With ARDS

Status: COMPLETED

Condition: Acute Respiratory Distress Syndrome, Adult

Interventions: Reparixin 600 mg tablets, administered crushed through nasogastric tube at the dose of 1200 mg TID (2 tablets TID administered approximately about eve

Date: 2022-08-04

TELESCOPE- TELEhealth Shared Decision-making COaching

Status: Completed

Condition: Lung Neoplasms

Interventions: The TELESCOPE intervention involves three complementary components: 1) decision aid and coaching for LCS, 2) referral of current smokers to evidence-b

Date: 2022-08-04

Expiratory Muscle Strength Training for Hypernasal Speech in Children

Status: NOT_YET_RECRUITING

Condition: Velopharyngeal Insufficiency

Interventions: At visit 1, participants will be block randomized based on PWSS score (3-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no

Date: 2022-08-04

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Status: Completed

Condition: Puberty; Precocious, Central

Interventions: All subjects will be pediatric patients with central precocious puberty.
They will be injected twice with a depot formulation containing 42 mg of

Date: 2022-08-04

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Status: COMPLETED

Condition: Hereditary Angioedema (HAE)

Interventions: No Intervention will be administered in this study.

Date: 2022-08-04

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Status: Completed

Condition: TNBC - Triple-Negative Breast Cancer

Interventions: Pembrolizumab 200 mg is administered intravenously at Week 1, then every 3 weeks during the treatment period (6 weeks).
Therapy will continue for

Date: 2022-08-04

Add-on Reparixin in Adult Patients With ARDS

Status: Completed

Condition: Acute Respiratory Distress Syndrome, Adult

Interventions: Reparixin will be administered through a nasogastric tube at the dose of 1200 mg (2 x 600 mg tablets) TID every 8 hours (6 tablets daily) for 14 days.

Date: 2022-08-04

Post Market Clinical Evaluation of Gamma 4

Status: Completed

Condition: Femoral Fracture

Interventions: The Gamma4 Nailing System is is indicated for the treatment of stable and unstable fractures as well as for stabilization of bones and correction of b

Date: 2022-08-04

Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South

Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Interventions: Intervention participants will download the TT-C app from the iOS or Google Play store and complete the intervention within one month.

Date: 2022-08-03

Shortened Course Adjuvant Radiotherapy Following TORS

Status: Completed

Condition: Oropharyngeal Squamous Cell Carcinoma

Interventions: Shortened Course Adjuvant Radiotherapy Following TORS

Date: 2022-08-03